~~<i id='6F30AA34B3'><strike id='6F30AA34B3'><tt id='6F30AA34B3'><pre id='6F30AA34B3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：explore 2025-09-29 22:37:14 - browse：114

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Chris Christie meets with Zelenskyy during Ukraine trip

Wikipedia

focus

entertainment

knowledge

leisure time

explore

9:49AmandaZurawski,whodevelopedsepsisandnearlydiedafterbeingrefusedanabortionwhenherwaterbrokeat18we

WSS

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

FDA scientists endorse Pfizer/BioNTech Covid

Vertex non

Medicare slashes safety net hospital payments by nearly $1 billion

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

The cancer stories no one wants to hear

knowledge

leisure time

Wikipedia

How to save PrEP access — and even expand it

Vertex non

United colonoscopy coverage change 'may cost lives,' doctors say

Investment in vaccine development is lagging, report finds

BioMarin wins approval for gene therapy to treat hemophilia A

The Affordable Care Act has saved billions in health care costs

Cancer drug shortages should be causing more outrage

'Null' research findings aren't empty of meaning. Let's publish them

The high cost of giving birth even with insurance

Readout Newsletter: The latest on Novavax, Merck, Bluebird

focus

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Biotech startup Celsius cuts 75% of staff ahead of first trial start

The a glaring gap in research on serious mental illness and primary care

Reconstructing family trees of blood cells may help predict disease

Merck, Johnson & Johnson CEOs will testify on high drug prices

Medicare drug price negotiation legal challenge met with skepticism

entertainment

knowledge

leisure time

explore